Disposition of sodium valproate in epileptic patients.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  1978-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1365-2125.1978.TB01663.XPMID 350251PMCID PMC1429371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of valproic acid after oral and intravenous administration

  1978cited by this paper
• Determination of the Anticonvulsant Drug—Dipropyl Acetate (Epilim) in Human Plasma by Gas Chromatography

  1977cited by this paper
• Valproate may lower serum-phenytoin.

  1977cited by this paper
• Pharmacokinetics and bioavailability of sodium valproate

  1977cited by this paper
• Letters to the EditorVALPROATE MAY LOWER SERUM-PHENYTOIN

  1976cited by this paper
• Pharmacokinetics of di-n-propylacetate in epileptic patients

  1975cited by this paper
• Commentary: a physiological approach to hepatic drug clearance.

  1975cited by this paper
• Changes in drug metabolism with increasing age: 2. phenytoin clearance and protein binding.

  1975cited by this paper
• A physiological approach to hepatic drug clearance

  1975cited by this paper
• Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

  1974cited by this paper
• Biopharmaceutics and Relevant Pharmacokinetics

  1971cited by this paper

• Assessing Liver Effects of Cannabidiol and Valproate Alone and in Combination Using Quantitative Systems Toxicology

  2023cites this paper
• Physiologically based pharmacokinetic modeling of disposition and drug‐drug interactions for valproic acid and divalproex

  2018influential citation
• Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update

  2018cites this paper
• Mechanisms of hyperexcitability and efficacy of antiepileptic drugs in hippocampal-entorhinal networks in the Reduced Intensity Status Epilepticus (RISE) model of chronic epilepsy

  2017cites this paper
• Clinical Outcomes of Concomitant Use of Warfarin and Selective Serotonin Reuptake Inhibitors: A Multidatabase Observational Cohort Study

  2017cites this paper
• Refractory Status Epilepticus

  2017cites this paper
• Drugs Commonly Used to Treat Refractory Status Epilepticus in Clinical Practice

  2017cites this paper
• Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine

  2017cites this paper
• Intramuscular and rectal therapies of acute seizures.

  2015cites this paper
• Dried blood spots for monitoring and individualization of antiepileptic drug treatment.

  2015cites this paper
• Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy

  2015cites this paper
• Pharmacokinetics, drug interactions, and tolerability of valproate.

  2015cites this paper
• A physiologically based pharmacokinetic model for Valproic acid in adults and children.

  2014cites this paper
• Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva

  2013cites this paper
• Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.

  2013cites this paper
• Intermittent drug dosing intervals guided by the operational multiple dosing half lives for predictable plasma accumulation and fluctuation

  2011cites this paper
• Management of refractory status epilepticus at a tertiary care centre in a developing country.

  2010cites this paper
• Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers

  2010cites this paper
• Phenobarbital, Primidone and Other Barbiturates

  2009cites this paper
• Oralvalproicacidfor epilepsy-long-termexperience intherapyandsideeffects

  2008cites this paper
• Oral valproic acid for epilepsy--long-term experience in therapy and side effects.

  2008cites this paper
• Oral valproic acid for epilepsy - long-term experience in therapy and side effects

  2008cites this paper
• Increased Apparent Oral Clearance of Valproic Acid during Intake of Combined Contraceptive Steroids in Women with Epilepsy

  2006cites this paper
• Valproate as a Mainstay of Therapy for Pediatric Epilepsy

  2006cites this paper
• Development of Sustained-Release Tablets Containing Sodium Valproate: In Vitro and In Vivo Correlation

  2006cites this paper
• Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrations.

  2006cites this paper
• The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.

  2006cites this paper
• Derzeitiger Stellenwert intravenöser Valproinsäure in der Therapie des generalisierten tonisch-klonischen Status epilepticus

  2005cites this paper
• Pharmacokinetics of sodium valproate in epileptic patients: Prediction of maintenance dosage by single-dose study

  2004cites this paper
• Valproic acid disposition in epileptic patients during combined antiepileptic maintenance therapy

  2004cites this paper
• Comparative kinetics of phenobarbital after administration of the acid and the propylhexedrine salt (barbexaclone)

  2004cites this paper
• Effects on cimetidine bioavailability of metoclopramide and antacids given two hours apart

  2004cites this paper
• Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage

  2004cites this paper
• Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy.

  2003cites this paper
• Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients

  2003cites this paper
• Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy.

  2003cites this paper
• Drug Treatment of Epilepsy in Elderly People

  2003cites this paper
• Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs.

  2003cites this paper
• Recent developments in treatment of status epilepticus: a review.

  2002cites this paper
• Pharmacological and Therapeutic Properties of Valproate

  2002cites this paper
• Valproate: a practical review of its uses in neurological and psychiatric disorders

  2002cites this paper
• Population pharmacokinetics of intravenous valproic acid in Korean patients

  2002cites this paper
• Intravenöse Valproinsäuretherapie zur Statusbehandlung

  2002cites this paper
• Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding

  2001cites this paper
• Stellenwert von intravenösem Valproat beim Status epilepticus

  2001cites this paper
• Investigation of Phenobarbital-Carbamazepine-Valproic Acid Interactions using Population Pharmacokinetic Analysis for Optimisation of Antiepileptic Drug Therapy: An Overview

  2000cites this paper
• Therapie des generalisierten tonisch-klonischen Status epilepticus im Erwachsenenalter

  2000cites this paper
• [The use of intravenous valproate].

  1999cites this paper
• Population‐based investigations of drug relative clearance using nonlinear mixed‐effect modelling from information generated during the routine clinical careof patients

  1999cites this paper
• Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data

  1999cites this paper
• Treatment Options for Acute Seizure Care

  1998cites this paper
• Anticonvulsant Therapy in Aged Patients

  1997cites this paper
• Population‐Based Investigation of Valproic Acid Relative Clearance Using Nonlinear Mixed Effects Modeling: Influence of Drug‐Drug Interaction and Patient Characteristics

  1997cites this paper
• The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers.

  1997cites this paper
• The tolerability and safety of valproate sodium injection given as an intravenous infusion

  1997cites this paper
• New drug therapy for acute seizure management.

  1997cites this paper
• Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine

  1996cites this paper
• Optimisation of Antiepileptic Drug Therapy

  1996cites this paper
• Pharmacokinetic Interactions Between Antiepileptic Drugs

  1996cites this paper
• A Model for Estimating Individualized Valproate Clearance Values in Children

  1995cites this paper
• Pharmacokinetic Study of Valproic Acid Sustained‐Release Preparation in Patients Undergoing Brain Surgery

  1995cites this paper
• Safety of intravenous valproate

  1995cites this paper
• Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.

  1994cites this paper
• Use of Injectable Valproic Acid in Status Epilepticus

  1993cites this paper
• Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance

  1993cites this paper
• Influence of co-medication on the metabolism of valproate

  1992cites this paper
• Δ2-Valproate biotransformation using human liver microsomal fractions

  1992cites this paper
• Valproic acid treatment of experimental status epilepticus.

  1992cites this paper
• Effects of administration route on valproate pharmacokinetics in the rabbit

  1991cites this paper
• Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4‐ene‐valproate, a hepatotoxic metabolite of valproic acid

  1990cites this paper
• Pharmacokinetic Drug Interactions with Phenytoin (Part II)

  1990cites this paper
• Clinically Relevant Anti-Epileptic Drug Interactions

  1990cites this paper
• Impaired Bioavailability of Famotidine Given Concurrently with a Potent Antacid

  1989cites this paper
• Factors modifying valproate plasma level/dose ratio: age, sex, dose and plasma level.

  1989cites this paper
• Pharmacologic interactions between valproate and other drugs.

  1988cites this paper
• Pharmacokinetics of Valproic Acid and Its Metabolites after a Single Oral Administration of a Sustained-Release Preparation of Sodium Valproate(KW-6066 N)

  1988cites this paper
• Inhibition by erythromycin of the conversion of carbamazepine to its active 10,11-epoxide metabolite.

  1987cites this paper
• An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis

  1987cites this paper
• [Bioavailability of a valproic acid preparation. The relative bioavailability of enteric-resistant valproic acid preparations in tablet form with simultaneously administered tetradeuterated valproic acid as the bioavailability reference].

  1986cites this paper
• Neurotransmitter receptors, endocrine responses and the biological substrates of depression: A review

  1986cites this paper
• Valproic acid pharmacokinetics in children: III. Very high dosage requirements.

  1986cites this paper
• Clinical Pharmacokinetics of Antiepileptic Drugs

  1985cites this paper
• Concurrent determination of valproic acid with other antiepileptic drugs by high-performance liquid chromatography.

  1985cites this paper
• An Update on Sodium Valproate

  1985cites this paper
• Concentration-Effect Relationships of Valproic Acid

  1985cites this paper
• Single-dose kinetics and bioavailability of sodium-hydrogen divalproate.

  1985cites this paper
• Valproic acid pharmacokinetics in children. II.

  1985cites this paper
• Comparison of steady-state pharmacokinetics of valproic acid in children between monotherapy and multiple antiepileptic drug treatment.

  1985cites this paper
• Valproate: an updated review

  1985cites this paper
• Antiepileptic Drug Interactions

  1985cites this paper
• In vivo plasma protein binding interaction between valproic acid and naproxen

  1984cites this paper
• Clinical Pharmacokinetics of Valproic Acid in Children with Seizures

  1984cites this paper
• The clinical pharmacology of antiepileptic drugs.

  1984cites this paper
• Variability in Level‐Dose Ratio of Valproate: Monotherapy Versus Polytherapy

  1984influential citation
• Use of hexadeuterated valproic acid and gas chromatography-mass spectrometry to determine the pharmacokinetics of valproic acid.

  1984cites this paper
• Pharmacokinetics of valproic acid in the elderly.

  1984cites this paper
• Effect of sustained release on the pharmacokinetics of valproic acid in the dog

  1984cites this paper
• First-Dose and Steady-State Pharmacokinetics of Valproic Acid in Children with Seizures

  1983cites this paper
• Valproate glucuronidation by rat liver microsomes. Interaction with parahydroxyphenobarbital.

  1983cites this paper
• Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients.

  1983cites this paper